The large chemical shift at 4.4 ppm and exchange rate in the slow-intermediate exchange regime make ADH a nice CEST contrast agent which should be readily detected on 3T scanners, and the in vivo imaging showed nice CEST contrast from ADH in tumors, indicating its potential in cancer imaging. The gene discussed is AVP; the disease is cancer.